Epidemic Expert Kang On Tackling nCoV And Science As A Leveler
Gagandeep Kang of the Translational Health Science and Technology Institute and Coalition for Epidemic Preparedness Innovations talks to Scrip about early efforts to tackle nCoV-2019 and shares glimpses into her life journey in a wide-ranging interview.
You may also be interested in...
Codagenix, a company backed by Novartis, Merck and the Bill & Melinda Gates Foundation, has tied up with India’s Serum Institute to develop a vaccine against SARS-CoV-2, joining a heated race against the dreaded COVID-19 outbreak.
Among other Asia deals, Takeda adds to pair of recent gene therapy tie-ups with a CNS-focused cell therapy partnership with Immusoft; earlier it licensed ex-US rights to JCR’s Hunter syndrome drug.